STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS

The authors have analyzed the literature dealing with studies of the efficiency and safety of stem cell transplantation (SCT) in patients with ankylosing spondylitis (AS) through the electronic resources Pubmed and Medline by using the keywords «bone marrow transplantation», «hematopoietic stem cell...

Full description

Bibliographic Details
Main Authors: I. Z. Gaidukova, V. V. Ushakova, A. P. Rebrov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2016-12-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/724
_version_ 1826556894984011776
author I. Z. Gaidukova
V. V. Ushakova
A. P. Rebrov
author_facet I. Z. Gaidukova
V. V. Ushakova
A. P. Rebrov
author_sort I. Z. Gaidukova
collection DOAJ
description The authors have analyzed the literature dealing with studies of the efficiency and safety of stem cell transplantation (SCT) in patients with ankylosing spondylitis (AS) through the electronic resources Pubmed and Medline by using the keywords «bone marrow transplantation», «hematopoietic stem cell transplantation», «ankylosing spondylitis», «autoimmune diseases», and «sacroiliac joint biopsy». The paper describes four cases of SCT in AS patients, including transplantation that was carried out in one patient with lymphoma concurrent with AS, in two AS patients without blood cancers, and in one patient with AS concurrent with myeloid leukemia. Drug-free remission was achieved in 3 cases: lymphoma concurrent with AS (n=1), AS concurrent with myeloid leukemia (n=1), and AS without comorbidities (n=1). In addition to an improvement in the course of AS, there were also two cases with clinical presentations of AS after SCT. The given cases show that SCT can be basically used to induce drug-free remission in patients with severe forms of standard therapy-resistant AS. However, the introduction of SCT in clinical practice needs to adjust the technique to the specific features of AS patients.
first_indexed 2024-04-10T02:07:19Z
format Article
id doaj.art-3ea18bb5be3d44a0846b1f3016eb6491
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2025-03-14T08:19:58Z
publishDate 2016-12-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-3ea18bb5be3d44a0846b1f3016eb64912025-03-02T13:10:59ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2016-12-01104879110.14412/1996-7012-2016-4-87-912009STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITISI. Z. Gaidukova0V. V. Ushakova1A. P. Rebrov2V.I. Razumovsky Saratov State Medical UniversityV.I. Razumovsky Saratov State Medical UniversityV.I. Razumovsky Saratov State Medical UniversityThe authors have analyzed the literature dealing with studies of the efficiency and safety of stem cell transplantation (SCT) in patients with ankylosing spondylitis (AS) through the electronic resources Pubmed and Medline by using the keywords «bone marrow transplantation», «hematopoietic stem cell transplantation», «ankylosing spondylitis», «autoimmune diseases», and «sacroiliac joint biopsy». The paper describes four cases of SCT in AS patients, including transplantation that was carried out in one patient with lymphoma concurrent with AS, in two AS patients without blood cancers, and in one patient with AS concurrent with myeloid leukemia. Drug-free remission was achieved in 3 cases: lymphoma concurrent with AS (n=1), AS concurrent with myeloid leukemia (n=1), and AS without comorbidities (n=1). In addition to an improvement in the course of AS, there were also two cases with clinical presentations of AS after SCT. The given cases show that SCT can be basically used to induce drug-free remission in patients with severe forms of standard therapy-resistant AS. However, the introduction of SCT in clinical practice needs to adjust the technique to the specific features of AS patients.https://mrj.ima-press.net/mrj/article/view/724spondyloarthritisankylosing spondylitisstem cell transplantationautoimmune diseasessacroiliac joint biopsy
spellingShingle I. Z. Gaidukova
V. V. Ushakova
A. P. Rebrov
STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
Современная ревматология
spondyloarthritis
ankylosing spondylitis
stem cell transplantation
autoimmune diseases
sacroiliac joint biopsy
title STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
title_full STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
title_fullStr STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
title_full_unstemmed STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
title_short STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
title_sort stem cell transplantation as a possible strategy for treating standard therapy resistant ankylosing spondylitis
topic spondyloarthritis
ankylosing spondylitis
stem cell transplantation
autoimmune diseases
sacroiliac joint biopsy
url https://mrj.ima-press.net/mrj/article/view/724
work_keys_str_mv AT izgaidukova stemcelltransplantationasapossiblestrategyfortreatingstandardtherapyresistantankylosingspondylitis
AT vvushakova stemcelltransplantationasapossiblestrategyfortreatingstandardtherapyresistantankylosingspondylitis
AT aprebrov stemcelltransplantationasapossiblestrategyfortreatingstandardtherapyresistantankylosingspondylitis